 | Shreya Life Sciences Private Limited | ||
| |||
| |||
| |
Shreya Life Sciences Private Limited |
| Shreya House,6th Floor, 301/a, Pereira Hill Road,andheri East Mumbai Maharashtra Country: India Telephone: 6938222 Fax: N/A |  |
Top Export Product Information of Shreya Life Sciences Private Limited |
| HS Code | Product Description |
| 30039011 | Prednisolone Sodium Phosphate Inj 30mg/m L 1ml Each Cont Predntsolone Sodium Phos Phate B P Equvalen |
| 30039089 | Sion Sr.no. A361. Piperazine Citrate Bp 88/usp |
| 30039090 | Syrup/oral Suspensionca-2409 Klaridol Syrup (loratadine Syrup) |
| 30041010 | (sion No.a-70) Revalgin Injection (analg In I.p.500mg,pitofenone Hcl 2.0mg,fenpiv Rinium Bromide 0.0 |
| 30043911 | Clotrimazole Cream 1% |
Export Shipment database details of Shreya Life Sciences Private Limited |
| Date | HS Code | Description | India Port | Foreign Port | Foreign Country | Quantity | Unit of Quantity |
| 26-2-2004 | 30039011 | Prednisolone Sodium Phosphate Inj 30mg/m L 1ml Each Cont Predntsolone Sodium Phos Phate B P Equvalen | Bombay Air | Moscow | Russia | 55040 | Pac |
| 31-3-2003 | 30039089 | Sion Sr.no. A361. Piperazine Citrate Bp 88/usp | Bombay Air | Harare | Zimbabwe | 500 | Kgs |
| 19-2-2004 | 30039090 | Prednisolone Sodium Phosphate Inj.30 Mg Ml,1ml(each Ml Containing Prednisolone Sodium Phosphate B | Bombay Air | Moscow | Russia | 57600 | Pac |
| 07-4-2004 | 30039090 | Syrup/oral Suspensionca-2409 Klaridol Syrup (loratadine Syrup) | Bombay Air | Almaatty | Kazakistan | 216 | Btl |
| 08-11-2004 | 30041010 | (sion No.a-70) Revalgin Injection (analg In I.p.500mg,pitofenone Hcl 2.0mg,fenpiv Rinium Bromide 0.0 | Bombay Air | Tashkent | Uzbekistan | 2400 | Pac |
| 30-10-2003 | 30043911 | Clotrimazole Cream 1% | Jnpt | Moscow | Russia | 141120 | Pac |
Exporters in similar top 5 hs codes |
| » Shraddha Exports |
List of other Alphabets |
 | A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R, S<< , T, U, V, W, X, Y, Z |
| Home | About us | Services | Contact us | Sitemap | Inquiry Basket(0) | Send Inquiry |